TriSalus Life Sciences, Inc.
USD4.74
+0.01 (+0.21%)
CEO
Mary T. Szela
IPO Date
2021-02-08
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Open
$4.73
Prev. Close
$4.73
Day Low
$4.59
Day High
$4.84
52W Low
$2.20
52W High
$7.95
Market Cap
$0.18B
Volume
0.29M
| 60,000 |
| $2.53 |
| 18 May 2026 | Stansky Michael P | director | P-Purchase | Acquired | 410,000 | $2.50 |
| 18 May 2026 | Stansky Michael P | director | P-Purchase | Acquired | 200,000 | $2.50 |
| 18 May 2026 | Szela Mary T | director, officer: CEO and President | P-Purchase | Acquired | 39,682 | $2.59 |
| 18 May 2026 | Patience David | Chief Financial Officer | P-Purchase | Acquired | 7,100 | $2.43 |
| 18 May 2026 | Gordon Gary B. | director | P-Purchase | Acquired | 10,000 | $2.46 |
| 15 May 2026 | HICKS KERRY R | director | A-Award | Acquired | 28,201 | $0.00 |
| 15 May 2026 | HICKS KERRY R | director | A-Award | Acquired | 56,403 | $2.52 |
| 15 May 2026 | Wahlstrom Mats | director | A-Award | Acquired | 37,602 | $0.00 |